Disease relevance of Flurtamone

• PURPOSE: Benchmark analysis of patients with chronic myeloid leukemia (CML) alive for more than 10 years after allogeneic bone marrow transplantation (BMT) including data on disease status, bone marrow reserve, long-term complications, and quality of life (QOL) [1].
• In contrast, the Benchmark Dose approach can provide estimates of the magnitude of sperm count reduction at a regulatory level, and the Quantitative Risk Estimation approach can provide estimates of exposure-induced infertility [2].
• The association between erectile dysfunction (ED) and acute myocardial infarction (AMI) among men was examined in the Integrated Healthcare Information Services National Managed Care Benchmark Database (IHCIS) [3].
• PURPOSE: Benchmark data regarding quality measures of breast cancer management are needed [4].
• Dose-response assessments for developmental toxicity. IV. Benchmark doses for fetal weight changes [5].

Psychiatry related information on Flurtamone

• The association between panic disorder and erectile dysfunction (ED) among men was examined in the Integrated Healthcare Information Services National Managed Care Benchmark Database (IHCIS) [6].

High impact information on Flurtamone

• RESULTS: The MIPS Bacterial Functional Annotation Benchmark dataset (MIPS-BFAB) is a new, high-quality resource comprising four bacterial genomes manually annotated according to the MIPS functional catalogue (FunCat) [7].
• The Sequence Alignment Benchmark (SABmark) provides sets of multiple alignment problems derived from the SCOP classification [8].
• The device was adopted as NEMA standard XR 21-2000, "Characteristics of and Test Procedures for a Phantom to Benchmark Cardiac Fluoroscopic and Photographic Performance," in August 2000 [9].
• Empirical methods, such as reduction of the No-Observed-Adverse-Effect-Level or a Benchmark Dose by uncertainty factors, incorporate human variability only qualitatively by use of an uncertainty factor [10].
• Patients aged 65 years or older initiating therapy with paroxetine CR or paroxetine IR with a diagnosis of anxiety were identified from the Integrated Healthcare Information Services National Managed Care Benchmark database from July 2001 to February 2004 [11].

Biological context of Flurtamone

• Status of geriatric education in colleges of osteopathic medicine: report of the First National Survey to Establish Benchmark Data [12].
• The Telemedicine Benchmark, a specific tool defined by the authors, was applied to measure the overall systems performances in terms of time delays during basic rate ISDN connections (128 Kbit/s) [13].
• The first benchmark problem (BM1) described a monospecies biofilm growing in a completely mixed reactor environment and had the purpose of comparing the ability of the models to predict substrate fluxes and concentrations for a biofilm system of fixed total biomass and fixed biomass density [14].

Gene context of Flurtamone

• A conceptual framework of the four key components of CSHM is presented: (a) Web-based Interface (templates); (b) Knowledge Base; (c) Output Data; and (d) Benchmark Group. RESULTS: The combined effect of these components results in a system that enables speedy performance assessment of safety and health activities on construction sites [15].
• Using the Verona Benchmark to introduce health promotion concepts and the investment for health approach in the city of Nova Gorica, Slovenia [16].

Analytical, diagnostic and therapeutic context of Flurtamone

• The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry [17].

References